tions to neuronal survival and neuritic growth. In: Fedoroff, S.; 55.
Vernadakis, A., eds. Astrocytes. Biochemistry, physiology and
pharmacology of astrocytes, vol. 2. Orlando: Academic Press,
Inc.; 1986:315-375.
45. McMullen, P. A.; Saint-Cyr, J. A.; Carlen, P. L.: Morphological 56.
alterations in the rat CA1 hippocampal pyramidal cell dendrites
resulting from chronic ethanol consumption and withdrawal. J.
Comp. Neurol. 225:111-118; 1984. 57.
46. Miyakawa, T.; Hattori, E.; Shikai, I4 Shimoji, A.; Nagatoshi, K.;
Suzuki, T.: Histopathological changes of chronic alcoholism.
Folia Psychiatr. Neurol. Jpn. 31:253-261; 1977. 58.
47. Montoliu, C.; Sancho-Tello, M.; Azorin, I.; Burgal, M.; Vall6s, S.;
Renau-Piqueras, J.; Guerri, C.: Ethanol increases cytochrome
P4502E1 and induces oxidative stress in astrocytes. J. Neuro- 59.
chem. 65:2561-2570; 1995.
48. Norton, W. T.; Aquino, D. A.; Hozumi, I.; Chiu, F. C.; Brosnan,
C. F.: Quantitative aspects of reactive gliosis: A review. Neurochem. Res. 17:877-885; 1992. 60.
49. O'Callaghan, J. P.; Miller, D. B.: Assessment of chemically
induced alterations in brain development using assays of neuronand glia-localized proteins. Neurotoxicology 10:393-406; 1989. 61.
50. Okaichi, H.; Oshima, Y.: Choice behavior of hippocampectomized
rats in the radial arm maze. Psychobiology 18:416421; 1990.
51. Popova, E. N.; Stschelkalina, G. A.: Effect of alcohol on glial 62.
cells. Zh. Nevropatol. Psikhiatr. 80:539-544; 1981.
52. Prunell, M.; Escorihuela, R. M.; Fernandez-Teruel, A.; Nunez, J. F.;
Tobena, A.: Anxiolytic profiles of alprazolam and ethanol in the
elevated plus maze test and the early acquisition of shuttle box 63.
avoidance. Pharmacol. Res. 29:37-46; 1994.
53. Rall, T. W.: Hypnotics and sedatives; ethanol. In: Gilman, A. G.;
Rall, T. W.; Nies, A. S.; Taylor, P., eds. The pharmacological 64.
basis of therapeutics. New York: Pergamon Press; 1990:345-382.
54. Reinhard, J. F., Jr.; Miller, D. B.; O'Callaghan, J. P.: The neurotoxicant MPTP (l-methyl-4-phenyl-l,2,3,6-tetra-hydropyridine) 65.
increases glial fibrillary acidic protein and decreases dopamine
levels of the mouse striatum: Evidence for glial response to
injury. Neurosei. Lett. 95:246-251; 1988.
